Analyst Reco. HealthEquity, Inc.

Equities

HQY

US42226A1079

Real-time Estimate Cboe BZX Other stock markets 12:36:30 2024-04-29 pm EDT			5-day change	1st Jan Change
80.74 ^USD	+0.60%		-0.68%	+21.62%

Apr. 04	JMP Securities Initiates Coverage on HealthEquity With Market Outperform Rating, $101 Price Target	MT
Apr. 02	JPMorgan Adjusts Price Target on HealthEquity to $108 From $86, Maintains Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JMP Securities Initiates Coverage on HealthEquity With Market Outperform Rating, $101 Price Target	Apr. 04	MT
JPMorgan Adjusts Price Target on HealthEquity to $108 From $86, Maintains Overweight Rating	Apr. 02	MT
Jefferies Adjusts HealthEquity Price Target to $95 From $79, Maintains Buy Rating	Mar. 28	MT
BTIG Research Adjusts HealthEquity Price Target to $110 From $100, Maintains Buy Rating	Mar. 20	MT
RBC Raises Price Target on HealthEquity to $92 From $90, Notes Fiscal Q4 Results at High End of Preannounced Ranges; Outperform Kept	Mar. 20	MT
Barrington Raises PT on HealthEquity to $100 From $85, Expects Improving Operating and Financial Performance, Keeps Outperform Rating	Feb. 26	MT
Barclays Adjusts HealthEquity's Price Target to $104 From $84, Keeps Overweight Rating	Feb. 23	MT
Deutsche Bank Adjusts HealthEquity Price Target to $95 From $88, Maintains Buy Rating	Feb. 23	MT
RBC Raises Price Target on HealthEquity to $90 From $77, Keeps Outperform Rating	Feb. 23	MT
Deutsche Bank Raises HealthEquity Price Target to $88 From $85, Maintains Buy Rating	Dec. 07	MT
Wells Fargo Adjusts HealthEquity's Price Target to $93 From $89, Maintains Overweight Rating	Dec. 06	MT
Deutsche Bank Raises HealthEquity's Price Target to $85 From $72, Maintains Buy Rating	23-10-26	MT
Baird Upgrades HealthEquity to Outperform From Neutral, Raises Price Target to $87 From $79	23-09-21	MT
Deutsche Bank Adjusts HealthEquity Price Target to $72 From $71, Maintains Buy Rating	23-09-07	MT
RBC Lifts PT on HealthEquity to $77 From $75 After Fiscal Q2 Beat, Fiscal 2024 Guidance, Keeps Outperform Rating	23-09-06	MT
Baird Adjusts Price Target on HealthEquity to $79 From $77, Maintains Neutral Rating	23-09-06	MT
Barrington Raises PT on HealthEquity to $85 From $80 After Fiscal Q2 Results Surpass Expectations, Maintains Outperform Rating	23-09-06	MT
RBC Lifts Price Target on HealthEquity to $77 From $75 After Fiscal Q2 Beat, Fiscal 2024 Guidance Boost, Keeps Outperform Rating	23-09-06	MT
JPMorgan Cuts HealthEquity's Price Target to $81 From $84, Maintains Overweight Rating	23-06-20	MT
Deutsche Bank Adjusts HealthEquity Price Target to $71 From $69, Maintains Buy Rating	23-06-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. HealthEquity, Inc.

Equities

HQY

US42226A1079

Analyst Reco.

Filters